COmmunity Mistrust and Measures of Institutional Trustworthiness (COMMIT)
COmmunity Mistrust and Measures of Institutional Trustworthiness (COMMIT)
批准号:
10545060
负责人:
C. DANIEL MULLINS
金额:
$59.13万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
已结题
起止时间:
2022-01-01 至 2023-11-30
关键词:
AddressAffectAsthmaBaltimoreBaptist ChurchBehaviorBehavioralCOVID-19COVID-19 disparityCOVID-19 impactCOVID-19 morbidityCOVID-19 mortalityCOVID-19 pandemicCOVID-19 preventionCOVID-19 susceptibilityCOVID-19 testingCenters for Disease Control and Prevention (U.S.)Clinical ResearchCollaborationsCommunicationCommunitiesContractsData ReportingDiabetes MellitusDisastersDiscriminationEconomicsEmotionalEthicsFosteringFoundationsFundingFutureGoalsGrantHealthHealth Disparities ResearchHealthcareHealthcare SystemsHypertensionInfrastructureInstitutionLebanonLightMarylandMeasuresMedicalMethodsModelingMorbidity - disease rateNational Center for Advancing Translational SciencesNational Institute on Minority Health and Health DisparitiesObesityOutcomePatientsPharmacy SchoolsPharmacy facilityPopulationPopulation GroupPublic HealthRADx Underserved PopulationsRecommendationResearchResearch PersonnelResourcesRiskRunningSARS-CoV-2 infectionSeminalTestingTraining ProgramsTranslational ResearchTreatment EffectivenessTrustUnderrepresented PopulationsUnderserved PopulationUnited StatesUnited States National Institutes of HealthUniversitiesVirginiaVulnerable PopulationsWorkWorkforce Developmentbehavior changecommunity engaged researchcommunity organizationsdisparity reductioneffectiveness evaluationethnic minority populationfightingfinancial relationshiphealth care deliveryhealth disparityhealth equityimprovedinfection rateinsightinter-institutionallenslong-standing disparitiesmedical vulnerabilitymembermortalitypandemic diseasepatient orientedpopulation healthpreferencepublic health emergencyracial biasracial minority populationracismshared decision makingsocialsocial health determinantssocial vulnerabilitytreatment programtrustworthinessuptake
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY/ABSTRACT
In the United States underserved and socially vulnerable populations have endured higher rates
and disparities of COVID-19 infection, morbidity, and mortality. This disproportionate burden
has shown the light on the root causes of COVID-19 disparities such as longstanding systemic
racial bias in health care delivery, discrimination, and poor social determinants of health that
lead to health disparities for medical conditions such as asthma, diabetes, hypertension, and
obesity, all of which increase risk and susceptibility to COVID-19 and its sequalae. To address
these root causes, academic and other research institutions and health care systems must shift
their lens from one that focuses solely on changing behaviors among underserved and
vulnerable populations. Behaviors among health care and research institutions must change to
breakdown the structural barriers to trust, testing, treatment, and prevention of COVID-19. Prior
to asking patients and community members to trust in research and researchers, the focus
should be on radical institutional transformation to advance trustworthiness.
Trying to address social, ethical, and behavioral issues (SEBI) influencing access acceptability
and uptake of COVID-19 testing during a pandemic is extremely challenging, yet achievable
when there are existing community-academic partnerships. The distinction between trust and
trustworthiness suggests that trustworthiness is an antecedent to trust. Our proposed study will
employ a continuous engagement approach to advance institutional trustworthiness and
improve the strength of an existing community-engaged research (CEnR) partnership as well as
develop recommendations for the formation of similar inter-institutional partnerships with
community organizations in underserved populations.
In collaboration with community and community-based pharmacy partners, our Aims are:
Aim 1: Codesign a sustainable model for trustworthy CEnR partnerships to address SEBI of
COVID-19 testing
Aim 2: Assess best practices of trustworthy CEnR partnerships to address COVID-19 testing
SEBI factors
Aim 3: Codevelop an ethically-congruent memorandum of commitment (MOC) template for
CEnR partnerships for COVID-19 testing to advance trust through trustworthiness,
transparency, and respect
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Developing InnoVative Equity-focused Regulatory SciencE (DIVERSE)
-
批准号:10838240
-
项目类别:
-
资助金额:$25.0万
-
财政年份:2023
-
负责人:C. DANIEL MULLINS
-
依托单位:
COmmunity Mistrust and Measures of Institutional Trustworthiness (COMMIT)
-
批准号:10447250
-
项目类别:
-
资助金额:$60.49万
-
财政年份:2022
-
负责人:C. DANIEL MULLINS
-
依托单位:
Agency for Health Research and Quality (AHRQ) R24 Conference Grant Program (R13)
-
批准号:9768971
-
项目类别:
-
资助金额:$4.84万
-
财政年份:2018
-
负责人:C. DANIEL MULLINS
-
依托单位:
PATIENTS: PATient-centered Involvement in Evaluating effectivNess of Treatment
-
批准号:8734404
-
项目类别:
-
资助金额:$99.41万
-
财政年份:2013
-
负责人:C. DANIEL MULLINS
-
依托单位:
PATIENTS: PATient-centered Involvement in Evaluating effectivNess of Treatment
-
批准号:8494177
-
项目类别:
-
资助金额:$99.53万
-
财政年份:2013
-
负责人:C. DANIEL MULLINS
-
依托单位:
PATIENTS: PATient-centered Involvement in Evaluating effectivNess of Treatment
-
批准号:8932009
-
项目类别:
-
资助金额:$96.93万
-
财政年份:2013
-
负责人:C. DANIEL MULLINS
-
依托单位:
PATIENTS: PATient-centered Involvement in Evaluating effectivNess of Treatment
-
批准号:9145184
-
项目类别:
-
资助金额:$98.72万
-
财政年份:2013
-
负责人:C. DANIEL MULLINS
-
依托单位:
PATIENTS: PATient-centered Involvement in Evaluating effectivNess of Treatment
-
批准号:9357515
-
项目类别:
-
资助金额:$96.41万
-
财政年份:2013
-
负责人:C. DANIEL MULLINS
-
依托单位:
Do Bayesian Adaptive Trials Offer Advantages for CER?
-
批准号:8036399
-
项目类别:
-
资助金额:$149.99万
-
财政年份:2010
-
负责人:C. DANIEL MULLINS
-
依托单位:
Response to Medicare Reimbursement Policy Change by Minority and All ESRD Patient
-
批准号:7496311
-
项目类别:
-
资助金额:$22.72万
-
财政年份:2008
-
负责人:C. DANIEL MULLINS
-
依托单位:
Response to Medicare Reimbursement Policy Change by Minority and All ESRD Patient
-
批准号:7682146
-
项目类别:
-
资助金额:$9.82万
-
财政年份:2008
-
负责人:C. DANIEL MULLINS
-
依托单位:
海外基金